drugset / Trial / NCT04800237
Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female participants with performance anxiety.
Timeline
- Start
- 2021-02-23
- Primary completion
- 2022-08-02
- Completion
- 2022-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VQW-765 | Unknown | — | Oral |
Indications
No indication recorded.